Elizabeth Barker | IR, KCSA Strategic Communications |
Dr. Carl Schwartz | CEO |
Bob Myers | CFO |
Jerry Vardzel | CEO, Helomics Corp |
Richard Gabriel | Board Member |
Good day, and welcome to the Precision Therapeutics Q3 2018 Business Update Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Elizabeth Barker, Investor Relations at KCSA Strategic Communications. Please go ahead.
Thank you all for participating in today's call to discuss Precision Therapeutics financial results for the third fiscal quarter of 2018.